iHABIO CPH. ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.1% 17.9% 9.0% 13.4% 16.7%  
Credit score (0-100)  14 8 26 16 9  
Credit rating  BB B BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  187 0 38 38 0  
Gross profit  74.6 57.5 2.1 11.1 0.0  
EBITDA  30.2 0.4 2.1 1.1 0.0  
EBIT  0.1 0.4 2.1 1.1 0.0  
Pre-tax profit (PTP)  0.1 0.4 1.7 0.4 -0.0  
Net earnings  0.1 0.3 1.3 0.3 -0.1  
Pre-tax profit without non-rec. items  0.1 0.4 1.7 0.4 -0.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  49.9 50.2 51.5 50.0 49.5  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  52.4 83.8 56.9 51.5 49.5  

Net Debt  -47.5 -83.8 -26.0 -32.5 -49.5  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  187 0 38 38 0  
Net sales growth  -82.8% -100.0% 0.0% 1.4% -100.0%  
Gross profit  74.6 57.5 2.1 11.1 0.0  
Gross profit growth  -89.1% -22.9% -96.3% 421.7% -100.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -10.0 0.0  
Balance sheet total (assets)  52 84 57 52 49  
Balance sheet change%  -14.0% 59.8% -32.1% -9.4% -4.0%  
Added value  30.2 0.4 2.1 11.1 0.0  
Added value %  16.2% 0.0% 5.7% 29.2% 0.0%  
Investments  -30 0 0 0 0  

Net sales trend  -2.0 -3.0 0.0 1.0 -1.0  
EBIT trend  2.0 3.0 4.0 5.0 0.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  16.2% 0.0% 5.7% 3.0% 0.0%  
EBIT %  0.0% 0.0% 5.7% 3.0% 0.0%  
EBIT to gross profit (%)  0.1% 0.7% 100.0% 10.3% 0.0%  
Net Earnings %  0.0% 0.0% 3.4% 0.8% 0.0%  
Profit before depreciation and extraordinary items %  16.2% 0.0% 3.4% 0.8% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 4.4% 1.1% 0.0%  
ROA %  0.1% 0.6% 3.0% 2.1% 0.0%  
ROI %  0.2% 0.8% 4.2% 2.3% 0.0%  
ROE %  0.2% 0.5% 2.5% 0.6% -0.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  95.2% 59.9% 90.5% 97.0% 100.0%  
Relative indebtedness %  1.3% 0.0% 14.4% 4.0% 0.0%  
Relative net indebtedness %  -24.0% 0.0% -54.7% -81.2% 0.0%  
Net int. bear. debt to EBITDA, %  -157.0% -21,880.2% -1,216.9% -2,845.1% 0.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  20.8 2.5 10.5 33.9 0.0  
Current Ratio  20.8 2.5 10.5 33.9 0.0  
Cash and cash equivalent  47.5 83.8 26.0 32.5 49.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  9.7 0.0 299.3 181.5 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 20.5 0.0  
Current assets / Net sales %  28.1% 0.0% 151.0% 134.9% 0.0%  
Net working capital  49.9 50.2 51.5 50.0 49.5  
Net working capital %  26.7% 0.0% 136.7% 130.9% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0